This will live in those special places not just in Knicks lore, not just in NBA lore, but in sports lore. This is one of the great comebacks — 29 points, most in NBA Finals history — in sports history ...
If the ratings have been phenomenal for the NBA Finals so far, the numbers for this Game 4 might defy superlatives. Or maybe, to take a cue from ABC play-by-play announcer Mike Breen, they might just ...
The National Science Foundation has been roiled by changes since President Trump took office for his second term. The administration canceled a slew of grants, cut its staff, ordered “senior ...
CNBC's Diana Olick reports on news regarding the housing market. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this ...
Earlier this week, Congressman Mike Thompson was honored by the Sutter County Board of Supervisors for his quick efforts to deliver $9 million in federal funding for a peach tree pull program after ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The university reached the ...
Anderson Cooper signed off of “60 Minutes” on Sunday with a salute to the newsmagazine’s editorial independence and longevity. He told viewers “I hope ’60 Minutes’ remains ’60 Minutes’ ” in a segment ...
The carrier's latest Keep and Switch offer helps cover up to $800 per line. By Katie Ann Lehman If you purchase an independently reviewed product or service through a link on our website, The ...
May 6 (Reuters) - Sanofi (SASY.PA), opens new tab has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the regulator's new fast-track review program, STAT News reported on ...
Since it was established nearly a year ago by the FDA, the Commissioner’s National Priority Voucher (CNPV) program has been steeped in controversy as a potential tool for government officials to curry ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.